journal
https://read.qxmd.com/read/38760442/idh-inhibition-in-gliomas-from-preclinical-models-to-clinical-trials
#41
REVIEW
Roberta Rudà, Craig Horbinski, Martin van den Bent, Matthias Preusser, Riccardo Soffietti
Gliomas are the most common malignant primary brain tumours in adults and cannot usually be cured with standard cancer treatments. Gliomas show intratumoural and intertumoural heterogeneity at the histological and molecular levels, and they frequently contain mutations in the isocitrate dehydrogenase 1 (IDH1) or IDH2 gene. IDH-mutant adult-type diffuse gliomas are subdivided into grade 2, 3 or 4 IDH-mutant astrocytomas and grade 2 or 3 IDH-mutant, 1p19q-codeleted oligodendrogliomas. The product of the mutated IDH genes, D-2-hydroxyglutarate (D-2-HG), induces global DNA hypermethylation and interferes with immunity, leading to stimulation of tumour growth...
July 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38945982/neuromodulation-for-severe-brain-injury-time-for-a-paradigm-shift
#42
JOURNAL ARTICLE
Aurore Thibaut, Géraldine Martens
No abstract text is available yet for this article.
June 30, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38945981/sensory-feedback-in-upper-limb-prosthetics-advances-and-challenges
#43
JOURNAL ARTICLE
Nebojša Malešević, Christian Antfolk
No abstract text is available yet for this article.
June 30, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38944655/non-invasive-deep-brain-stimulation-interventional-targeting-of-deep-brain-areas-in-neurological-disorders
#44
JOURNAL ARTICLE
Friedhelm C Hummel, Maximilian J Wessel
No abstract text is available yet for this article.
June 29, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38944654/non-invasive-stimulation-for-treating-cognitive-impairment-in-alzheimer-disease
#45
JOURNAL ARTICLE
Irena Rektorová
No abstract text is available yet for this article.
June 29, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38902466/neurology-under-the-midnight-sun-ean-congress-2024-comes-to-helsinki
#46
Heather Wood
No abstract text is available yet for this article.
June 21, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38866966/acceptable-performance-of-blood-biomarker-tests-of-amyloid-pathology-recommendations-from-the-global-ceo-initiative-on-alzheimer-s-disease
#47
REVIEW
Suzanne E Schindler, Douglas Galasko, Ana C Pereira, Gil D Rabinovici, Stephen Salloway, Marc Suárez-Calvet, Ara S Khachaturian, Michelle M Mielke, Chi Udeh-Momoh, Joan Weiss, Richard Batrla, Sasha Bozeat, John R Dwyer, Drew Holzapfel, Daryl Rhys Jones, James F Murray, Katherine A Partrick, Emily Scholler, George Vradenburg, Dylan Young, Alicia Algeciras-Schimnich, Jiri Aubrecht, Joel B Braunstein, James Hendrix, Yan Helen Hu, Soeren Mattke, Mark Monane, David Reilly, Elizabeth Somers, Charlotte E Teunissen, Eli Shobin, Hugo Vanderstichele, Michael W Weiner, David Wilson, Oskar Hansson
Anti-amyloid treatments for early symptomatic Alzheimer disease have recently become clinically available in some countries, which has greatly increased the need for biomarker confirmation of amyloid pathology. Blood biomarker (BBM) tests for amyloid pathology are more acceptable, accessible and scalable than amyloid PET or cerebrospinal fluid (CSF) tests, but have highly variable levels of performance. The Global CEO Initiative on Alzheimer's Disease convened a BBM Workgroup to consider the minimum acceptable performance of BBM tests for clinical use...
June 12, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38831097/potassium-regulation-could-be-key-to-healthy-brain-ageing
#48
JOURNAL ARTICLE
Ian Fyfe
No abstract text is available yet for this article.
June 4, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38831096/apoe-%C3%AE-4-homozygosity-a-genetic-form-of-alzheimer-disease
#49
JOURNAL ARTICLE
Ian Fyfe
No abstract text is available yet for this article.
June 4, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38831095/microglial-senescence-is-a-potential-therapeutic-target-for-alzheimer-disease
#50
JOURNAL ARTICLE
Heather Wood
No abstract text is available yet for this article.
June 4, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38811858/publisher-correction-the-miami-framework-for-als-and-related-neurodegenerative-disorders-an-integrated-view-of-phenotype-and-biology
#51
Michael Benatar, Joanne Wuu, Edward D Huey, Corey T McMillan, Ronald C Petersen, Ronald Postuma, Caroline McHutchison, Laynie Dratch, Jalayne J Arias, Anita Crawley, Henry Houlden, Michael P McDermott, Xueya Cai, Neil Thakur, Adam Boxer, Howard Rosen, Bradley F Boeve, Penny Dacks, Stephanie Cosentino, Sharon Abrahams, Neil Shneider, Paul Lingor, Jeremy Shefner, Peter M Andersen, Ammar Al-Chalabi, Martin R Turner
No abstract text is available yet for this article.
June 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38755449/deciphering-nociplastic-pain-clinical-features-risk-factors-and-potential-mechanisms
#52
REVIEW
Chelsea M Kaplan, Eoin Kelleher, Anushka Irani, Andrew Schrepf, Daniel J Clauw, Steven E Harte
Nociplastic pain is a mechanistic term used to describe pain that arises or is sustained by altered nociception, despite the absence of tissue damage. Although nociplastic pain has distinct pathophysiology from nociceptive and neuropathic pain, these pain mechanisms often coincide within individuals, which contributes to the intractability of chronic pain. Key symptoms of nociplastic pain include pain in multiple body regions, fatigue, sleep disturbances, cognitive dysfunction, depression and anxiety. Individuals with nociplastic pain are often diffusely tender - indicative of hyperalgesia and/or allodynia - and are often more sensitive than others to non-painful sensory stimuli such as lights, odours and noises...
June 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38744998/blood-test-for-early-parkinson-disease-diagnosis
#53
COMMENT
Lisa Kiani
No abstract text is available yet for this article.
June 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38744997/infant-microbiome-predicts-neurodevelopmental-disorders
#54
COMMENT
Lisa Kiani
No abstract text is available yet for this article.
June 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38724589/the-clinical-importance-of-suspected-non-alzheimer-disease-pathophysiology
#55
REVIEW
Stephanie J B Vos, Aurore Delvenne, Clifford R Jack, Dietmar R Thal, Pieter Jelle Visser
The development of biomarkers for Alzheimer disease (AD) has led to the origin of suspected non-AD pathophysiology (SNAP) - a heterogeneous biomarker-based concept that describes individuals with normal amyloid and abnormal tau and/or neurodegeneration biomarker status. In this Review, we describe the origins of the SNAP construct, along with its prevalence, diagnostic and prognostic implications, and underlying neuropathology. As we discuss, SNAP can be operationalized using different biomarker modalities, which could affect prevalence estimates and reported characteristics of SNAP in ways that are not yet fully understood...
June 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38454092/towards-the-era-of-biological-biomarkers-for-parkinson-disease
#56
COMMENT
Nobutaka Hattori
No abstract text is available yet for this article.
June 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38769202/the-miami-framework-for-als-and-related-neurodegenerative-disorders-an-integrated-view-of-phenotype-and-biology
#57
REVIEW
Michael Benatar, Joanne Wuu, Edward D Huey, Corey T McMillan, Ronald C Petersen, Ronald Postuma, Caroline McHutchison, Laynie Dratch, Jalayne J Arias, Anita Crawley, Henry Houlden, Michael P McDermott, Xueya Cai, Neil Thakur, Adam Boxer, Howard Rosen, Bradley F Boeve, Penny Dacks, Stephanie Cosentino, Sharon Abrahams, Neil Shneider, Paul Lingor, Jeremy Shefner, Peter M Andersen, Ammar Al-Chalabi, Martin R Turner
Increasing appreciation of the phenotypic and biological overlap between amyotrophic lateral sclerosis (ALS) and frontotemporal dementia, alongside evolving biomarker evidence for a pre-symptomatic stage of disease and observations that this stage of disease might not always be clinically silent, is challenging traditional views of these disorders. These advances have highlighted the need to adapt ingrained notions of these clinical syndromes to include both the full phenotypic continuum - from clinically silent, to prodromal, to clinically manifest - and the expanded phenotypic spectrum that includes ALS, frontotemporal dementia and some movement disorders...
May 20, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38745000/car-t-cells-offer-hope-in-glioblastoma
#58
JOURNAL ARTICLE
Ian Fyfe
No abstract text is available yet for this article.
May 14, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38744999/nanoprobe-for-blood-brain-barrier-changes
#59
JOURNAL ARTICLE
Lisa Kiani
No abstract text is available yet for this article.
May 14, 2024: Nature Reviews. Neurology
https://read.qxmd.com/read/38744996/genetic-protection-against-alzheimer-disease
#60
JOURNAL ARTICLE
Lisa Kiani
No abstract text is available yet for this article.
May 14, 2024: Nature Reviews. Neurology
journal
journal
42294
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.